Brinter and LED Tailor Partner

To implement an automatic photon disinfection system in the 3D bioprinter chamber

Bioprinting startup Brinter has today announced a partnership with LED Tailor to introduce a new disinfecting blue light feature embedded in its multi-material 3D bioprinting solution Brinter®. The system enables the safe production of e.g. tissue models and drugs, and minimizes the need for separate cleanrooms, making bioprinters more portable and safe.

Brinter is a modular bioprinter that is able to print multi-material and highly complex tissue structures in 3D, providing advanced features needed for bioprinting. The device can print both stiff and soft materials, including but not limited to liquids and hydrogels with living cells, bio-paste, metal with binder material, and thermoplastics, while being easy to set up in a lab in minutes.

Blue light is a part of the visible light spectrum, from 400 nm to approximately 500 nm wavelength. Disinfecting blue light, while being completely safe for human beings, kills all forms of bacteria, yeast, and mold. Opposite to UV-light (100–400nm), visible blue light does not deteriorate materials or cause other hazardous effects.

The discovery that all microbes contain blue light-sensitive compounds inside their cells as a part of their natural metabolism has been the key to creating this effective disinfection system.

When these light-sensitive compounds are exposed to specific wavelengths of disinfecting blue light with a certain light intensity, a destructive chemical reaction starts. The end products of this reaction are reactive oxygen radicals inside the microbial cell. Reactive oxygen species (ROS) are molecules containing a very reactive oxygen component, which has the ability to cause damage to any structure inside the microbial cell and destroy it from the inside.

“Our photon disinfection innovation is an automatic and sustainable solution to microbe problems. The system enables safe bioprinting, production of food and beverages, restrains epidemics, and answers the needs of cleanrooms. Our solutions improve safety and vitality of employees and reduce microbiological and chemical risks in healthcare and industrial sites,” says Harri Rautio, CEO at LED Tailor.

“The partnership with LED Tailor makes Brinter the first 3D bioprinter in the world using blue light disinfection technology that can be utilized both inside and outside of the device to clean the environment around the bioprinter,” says Tomi Kalpio, CEO at Brinter.

Customers of Brinter include bio and pharmaceutical companies like Nanoform, as well as research organizations like VTT, BEST group at the University of Glasgow, Johannes Gutenberg University of Mainz, the University of Oulu, University of Turku, Åbo Akademi, Tampere University, and the University of Helsinki.

To date, Brinter is currently active in over 10 countries, including the USA, Germany, India, and the UK. Last month, the company recently launched its new entry-level model, Brinter Core.

SourceBrinter

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”